MINNEAPOLIS, June 16, 2011 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ (CTT) technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), announced the appointment of Lisa Ackermann as its Vice President, Sales and Marketing effective June 16, 2011. Ms. Ackermann will report to the Company's Chief Executive Officer, Stryker Warren, Jr. Ms. Ackermann was most recently Group Product Director, Endoscopy for Ethicon Endo-Surgery (EES), a Johnson & Johnson Company.
